Related Experiment Video
Updated: Oct 30, 2025

09:45
Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
10.4K
High Fat Diet Aggravates AD-Related Pathogenic Processes in APP/PS1 Mice
Xiaokang Gong1, Zheng Liang1, Wei Liu1
1Institutes of Biomedical Sciences, School of Medicine, Jianghan University, Wuhan, China.
Current Alzheimer Research
|July 2, 2021
Summary
A high-fat diet (HFD) worsens Alzheimer's disease (AD) by increasing insulin resistance (IR) and amyloid-beta (Aβ) accumulation. This diet exacerbates cognitive decline and synaptic damage in AD mouse models.
Area of Science:
- Neuroscience
- Metabolic Disorders
- Aging Research
Background:
- Alzheimer's disease (AD) is a leading neurodegenerative disorder.
- Negative lifestyle factors, including high-fat diets (HFD), are implicated in AD pathogenesis.
- Insulin resistance (IR), often linked to HFD, is associated with increased risk of AD and amyloidogenesis.
Purpose of the Study:
- To investigate the impact of HFD on amyloidogenesis and cognitive deficits in AD model mice.
- To clarify the role of HFD-induced insulin resistance in Alzheimer's disease progression.
Main Methods:
- APP/PS1 mice, an established model for AD, were fed an HFD for four months.
- Evaluated insulin resistance in peripheral tissues and the brain.
- Assessed cognitive function, dendritic integrity, and synaptic protein expression.
- Measured the expression of BACE1 and IDE, key enzymes in amyloid-beta processing.
Main Results:
- HFD feeding increased insulin resistance in both the periphery and brain of APP/PS1 mice.
- Long-term HFD exacerbated cognitive deficits and impaired synaptic integrity.
- HFD led to increased BACE1 and decreased IDE expression, promoting beta-amyloid accumulation.
Conclusions:
- Long-term HFD, coupled with insulin resistance, promotes beta-amyloid toxicity and cognitive decline in AD models.
- Modifiable lifestyle factors, such as HFD-induced IR, may significantly contribute to Alzheimer's disease pathogenesis.
- These findings highlight the critical link between diet, metabolic health, and neurodegeneration.
Keywords:
Alzheimer's disease (AD)cognitive impairmentshigh fat diet (HFD)insulin resistance (IR)insulin-degrading enzyme (IDE)β-amyloid (Aβ)β-secretase (BACE1).More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
913
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
913
Alzheimer's Disease: Treatment
437
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
437

